Modernizing Brachytherapy Dose Calculation Practice
Updates on TG-43 and Brachytherapy Dosimetry Protocols remain central to safe, reproducible clinical practice. The formalism has supported sealed-source brachytherapy for decades, giving physicists a shared framework for converting source strength, geometry, and tissue dose data into treatment-planning information. Its continued value depends on understanding both what the model represents and where its assumptions become limiting.
For delegates attending the 2014 Annual Scientific Meeting of the Canadian Organization of Medical Physicists in Banff, these issues connected closely with daily responsibilities in treatment planning, commissioning, quality assurance, and clinical communication. A protocol update is useful when it improves consistency without encouraging users to treat calculated dose as more certain than the underlying measurements and source data allow.
Clinical Meaning Of The TG-43 Formalism
TG-43 describes dose around a brachytherapy source using a reference dose-rate constant, geometry factor, radial dose function, and anisotropy function. The approach is generally based on measurements or Monte Carlo calculations in a water medium, with the source positioned according to a defined coordinate system. This standardized structure allows treatment-planning systems from different vendors to produce comparable results when they use compatible source data.
The formalism is especially effective for many conventional low-dose-rate and high-dose-rate source models in water-equivalent conditions. It does not, however, fully describe dose perturbations from applicators, shielding, bone, air cavities, or tissue heterogeneity. Physicists must distinguish between the dose reported by a TG-43-based system and the physical dose distribution that exists in a patient with complex anatomy. The MRI perspective is particularly relevant where image guidance changes applicator reconstruction, target definition, and the interpretation of nearby organs at risk.
Why Protocol Updates Matter
Changes in brachytherapy technology have exposed the boundaries of older data sets. New source designs, miniature sources, hybrid applicators, interstitial techniques, and advanced imaging workflows require carefully validated parameters. An updated protocol can clarify source naming, reference conditions, uncertainty reporting, and the use of independently verified dosimetric data.
The main objective is clinical consistency. A source library should identify the manufacturer, model, encapsulation, active length, air-kerma strength convention, and data provenance. Small differences in source definitions can create meaningful discrepancies when they are combined with incorrect units, a mismatched anisotropy function, or an unsuitable dose-rate constant. Protocol governance therefore belongs within the department’s quality system rather than being treated as a one-time planning-system installation task.
A useful review also separates formal recommendations from local policy. National or international guidance may define accepted methods, while a centre must still document its own commissioning tests, approval authority, change control, and escalation process. This distinction makes future software upgrades and source replacements easier to manage.
Source Data, Geometry, And Heterogeneity
Source dosimetry begins with traceability. Air-kerma strength, source calibration, reference distance, and chamber-specific correction factors should be recorded in a way that permits independent review. The department should confirm that the calibration chain and source certificate use compatible quantities. Confusion between apparent activity, reference air-kerma rate, and air-kerma strength can propagate directly into treatment time or dwell-time errors.
Geometry deserves the same attention. Applicator reconstruction, dwell-position accuracy, transfer-tube indexing, and source offset corrections all influence the final dose distribution. A planning system can calculate highly precise numbers from an incorrectly reconstructed channel, so image registration and reconstruction checks are essential. For intracavitary and interstitial treatments, the team should also verify that the coordinate conventions used in source data match those used by the planning software.
TG-43’s water assumption becomes increasingly important near interfaces and high-density materials. Dose perturbations from bone, rectal gas, surgical clips, needles, and shielding may be clinically relevant, particularly in highly conformal plans or when an organ at risk lies close to an applicator. Model-based dose calculation algorithms can address some of these effects, but they bring new requirements for material assignment, cross-section selection, commissioning, and independent validation.
| Dosimetry element | What should be checked | Common risk |
|---|---|---|
| Source strength | Calibration quantity, units, certificate, and reference conditions | Activity and air-kerma strength treated as interchangeable |
| Dose-rate constant | Source model, literature or Monte Carlo origin, and local approval | Data imported for a similar but different source |
| Geometry function | Coordinate system, active length, and source orientation | Incorrect source definition or reconstruction offset |
| Radial dose function | Measurement range, interpolation, and extrapolation | Unsupported values used outside the validated region |
| Anisotropy function | Angular convention, tabulation, and software implementation | Orientation or sign convention mismatch |
| Heterogeneity correction | Material assignment and algorithm validation | TG-43 results interpreted as patient-specific absorbed dose |
Commissioning And Independent Verification
Commissioning should test the complete clinical chain rather than isolated equations. This includes source-data entry, plan calculation, applicator reconstruction, dwell positioning, treatment-unit transfer, record-and-verify communication, and final treatment delivery. A formal checklist can identify whether a discrepancy originates in the source model, imaging, planning software, hardware, or human workflow.
Independent calculations are valuable for representative cases. Hand calculations, spreadsheet checks, secondary software, and Monte Carlo comparisons can verify source strength scaling, inverse-square behaviour, dwell-time summation, and dose at selected points. The purpose is not to reproduce every planning-system voxel; it is to establish an independent expectation and define tolerances for clinically important quantities.
Quality assurance should include routine review of source exchange procedures, applicator integrity, emergency systems, and treatment records. For high-dose-rate services, timer accuracy and source-position verification deserve particular attention. For low-dose-rate implants, source inventory, loading patterns, and post-implant documentation require equally clear controls. Each test should have an owner, frequency, acceptance criterion, and documented response to failure.
Communicating Dose With Confidence
A dose value has meaning only when its calculation conditions are understood. Reports should identify the prescription, dose points or volume metrics, source model, planning algorithm, imaging data, and relevant assumptions. When TG-43 water-based results are used near an interface or shield, that limitation should be visible to the clinical team rather than hidden in technical documentation.
Communication also matters during multidisciplinary review. Radiation oncologists, therapists, radiologists, and physicists may use the same terms differently, especially for reference points, equivalent dose, and organ-at-risk constraints. A short explanation of how a metric was generated can prevent inappropriate comparison between plans calculated with different source data or algorithms.
Professional meetings strengthen that shared language. The archived account of a networking reception reflects the value of informal exchange alongside formal scientific sessions. Conversations among clinical physicists often reveal practical commissioning solutions, reporting conventions, and lessons from incidents that are difficult to capture in a protocol document.
Translating Guidance Into Local Practice
A department can turn protocol knowledge into a controlled implementation process. Begin with an inventory of active source models, planning systems, applicators, imaging pathways, and clinical techniques. Map each item to its supporting data and identify whether the information comes from a manufacturer, a peer-reviewed publication, a professional task group, or local measurement.
The implementation team should include medical physicists, radiation oncologists, therapists, information technology staff, and quality specialists where appropriate. Responsibilities need to be explicit, especially for approving source-library changes and releasing new planning templates. The delegate experience at a professional meeting illustrates how education, technical sessions, and operational planning fit together in a working clinical community.
Practical review priorities include:
- Verify every source model against its certificate, published data, and planning-system definition.
- Recalculate representative plans with an independent method before clinical release.
- Test applicator reconstruction, source offsets, channel indexing, and image-transfer workflows.
- Document limitations of water-based TG-43 calculations near heterogeneities and shielding.
- Record approval, training, change control, and post-implementation audit results.
A protocol should remain a living controlled document. New applicators, software releases, imaging modalities, and model-based algorithms can change the relevant risk profile. Scheduled review, incident learning, and participation in professional education help ensure that dosimetry practice evolves without losing traceability.
The COMP Banff archive provides a useful setting for revisiting how scientific updates, clinical workflows, and professional collaboration support safer brachytherapy. Use its program and conference resources to connect protocol concepts with commissioning records, local QA procedures, and multidisciplinary practice, then apply the resulting review to the source models and treatment techniques used in your department.